Ethyl 5-[1-(2-acetamidophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate;ethyl 5-[1-(2-aminophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate
C46H32Cl2F8N8O7 — CID 158152717
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 5-[1-(2-acetamidophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate;ethyl 5-[1-(2-aminophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate
Ethyl 5-[1-(2-acetamidophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate;ethyl 5-[1-(2-aminophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate (PubChem CID 158152717) has the molecular formula C46H32Cl2F8N8O7 and a molecular weight of 1031.70 g/mol. Its IUPAC name is ethyl 5-[1-(2-acetamidophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate;ethyl 5-[1-(2-aminophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate.
Molecular Properties
| Compound Name | Ethyl 5-[1-(2-acetamidophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate;ethyl 5-[1-(2-aminophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate |
|---|---|
| PubChem CID | 158152717 |
| Molecular Formula | C46H32Cl2F8N8O7 |
| Molecular Weight | 1031.70 g/mol |
| Exact Mass | 1030.16 |
| IUPAC Name | ethyl 5-[1-(2-acetamidophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate;ethyl 5-[1-(2-aminophenyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-(2-chloro-6-fluorophenyl)-1,2-oxazole-4-carboxylate |
| SMILES | CCOC(=O)c1c(-c2c(F)cccc2Cl)noc1-c1cnn(-c2ccccc2N)c1C(F)(F)F.CCOC(=O)c1c(-c2c(F)cccc2Cl)noc1-c1cnn(-c2ccccc2NC(C)=O)c1C(F)(F)F |
| InChI | InChI=1S/C24H17ClF4N4O4.C22H15ClF4N4O3/c1-3-36-23(35)19-20(18-14(25)7-6-8-15(18)26)32-37-21(19)13-11-30-33(22(13)24(27,28)29)17-10-5-4-9-16(17)31-12(2)34;1-2-33-21(32)17-18(16-12(23)6-5-7-13(16)24)30-34-19(17)11-10-29-31(20(11)22(25,26)27)15-9-4-3-8-14(15)28/h4-11H,3H2,1-2H3,(H,31,34);3-10H,2,28H2,1H3 |
| InChIKey | FVHVREFBAWUWSZ-UHFFFAOYSA-N |
| XLogP | 11.91 |
| TPSA | 195.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 71 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1031.70 |
| LogP ≤ 5 | 11.91 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158152717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.